Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIRLET7A1 - Matrigel 3D culture model of JIMT1 breast cancer cells
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIRLET7A1 - Interstitial fluid flow effect on noninvasive and invasive ERBB2-positive breast cancer cells
MIRLET7A1 - Influenza A effect on plasmacytoid dendritic cells
MIRLET7A1 - Pulmonary fibrosis with associated pulmonary hypertension: lung explants
MIRLET7A1 - Epithelial stem cells derived from induced pluripotent stem cells
MIRLET7A1 - Pandemic and seasonal influenza A H1N1 infection of differentiated type I-like alveolar epithelial cells in vitro
MIRLET7A1 - DEK oncogene deficiency effect in U937 leukemic monocyte lymphoma cells
MIRLET7A1 - Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma: microdissected tumor cells
MIRLET7A1 - Stem cell factor SOX2-deficient stomach carcinoma cell line: time course
MIRLET7A1 - Transcription factor ZNF395 effect on RTS3b skin cancer cell line
MIRLET7A1 - First, second and third trimester pregnancy: maternal cell-free plasma
MIRLET7A1 - CD43+/41+/235+ iPSC-derived progenitor cells with germ-line trisomy 21
MIRLET7A1 - Inflammatory myopathies
MIRLET7A1 - Protein kinase C δ deficiency effect on breast cancer cells
MIRLET7A1 - U2OS osteosarcoma cell line response to strigolactone analogs ST362 and MEB55: 6 hours
MIRLET7A1 - H3K79 histone methyl transferase DOT1L inhibitor EPZ004777 effect on breast cancer cells: dose response
MIRLET7A1 - Asthma: white blood cells
MIRLET7A1 - VprBP depletion effect on prostate cancer cell line
MIRLET7A1 - Androgen effect on carboxyl terminal-binding protein 2-deficient prostate cancer cell line
MIRLET7A1 - Lymphoblastoid cell response to low-dose cadmium exposure in vitro
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on